ALLONGE TO 4% CONVERTIBLE SENIOR NOTE4% Convertible Senior Note • September 14th, 2001 • Novavax Inc • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 14th, 2001 Company IndustryTHIS ALLONGE TO 4% CONVERTIBLE SENIOR NOTE (the “Allonge”), is made September 7, 2001, between King Pharmaceuticals, Inc. (“Payee”) and Novavax, Inc. (“Company”).